Breaking News

Avon Sets Schedule

November 14, 2005

Avon’s annual Walk for Breast Cancer series will take place April through September to raise awareness of the disease and help save lives, event organizers said. The walks are conveniently scheduled on Saturdays and Sundays. The event schedule is as follows: April 26-27, Washington, DC; May 3-4, Boston, MA; May 17-18, Cincinnati, OH; June 7-8, Chicago, IL; June 28 29, San Francisco, CA; July 12-13, Portland, OR; Sept. 6-7, Los Angeles, CA and Sept. 20-21, New York, NY.
Each participant is required to raise a minimum of $1,750 for the Avon Foundation Breast Cancer crusade. Walkers will be assigned a “walker buddy” in order to help with fundraising and training, event organizers said. More info: (877)-WALK-AVON; Web-site: www.avonfoundation.org.
  • Patent Activity: Colgate-Palmolive

    Patent Activity: Colgate-Palmolive

    December 6, 2016
    New oral care compositions, the use of radish root ferment filtrate in a cleanser and more.

  • Sparkle & Shine

    Sparkle & Shine

    Melissa Meisel, Associate Editor||November 21, 2016
    Glam packaging and upscale scent combos are big at Yankee Candle for Holiday 2016.

  • Cos Bar: Turning 40 and Hitting Fast Forward

    Cos Bar: Turning 40 and Hitting Fast Forward

    Christine Esposito, Associate Editor||November 21, 2016
    With a recent investor infusion, a new CEO and rebranding effort underway, this luxury beauty retailer has big plans.

  • Slow & Steady

    Slow & Steady

    Tom Branna, Editorial Director||December 1, 2016
    In a tumultuous environment, steady gains posted in the industrial and institutional cleaning sector are welcomed.

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna, Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • The Plex  Phenomenon

    The Plex Phenomenon

    Denise Costrini, Croda North America||December 1, 2016
    Croda details the hair-protecting qualities of bond multipliers and the company’s new bond-building formulation system.